CVS beat Wall Street’s expectations in the fourth quarter, but investors — unhappy that the healthcare giant didn’t change its outlook for 2026 — still sent CVS’ stock down after the company released ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results